Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2008

To view an abstract, select an author from the vertical list on the left side.

2008 Grants - Li

Modulation of the Gamma-Secretase Complex and Activity by Individual Subunits

Yueming Li, Ph.D.
Sloan-Kettering Institute for Cancer Research
New York, New York

2008 Investigator-Initiated Research Grant

Alzheimer's disease is characterized by the accumulation of the protein fragment beta-amyloid. Scientists believe this fragment disrupts cell-to-cell communication and causes brain cell death in Alzheimer's. Beta-amyloid is clipped from its parent molecule in a two-stage process. The second cut is made by gamma-secretase, a complex of several proteins. One group of gamma-secretase proteins, the presenilin group, is encoded by various PS genes. Mutations in the PS1 and PS2 genes are associated with a greater risk of obtaining familial, or inherited, Alzheimer's. However, other gamma-secretase components likely play important roles in Alzheimer development.

Yueming Li, Ph.D., and colleagues hypothesize that mutated PS1 and PS2 genes work with other gamma-secretase components to promote excessive beta-amyloid production. For this grant, the researchers plan to test their hypothesis using cultured cells.

Results from Dr. Li's study could help clarify the biological mechanisms underlying toxic beta-amyloid production. Such knowledge could lead to novel therapies for treating Alzheimer's disease at its earliest stages.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.